[go: up one dir, main page]

ES2001061A6 - Un procedimiento para la preparacion de una forma de dosificacion rectal medicamentosa. - Google Patents

Un procedimiento para la preparacion de una forma de dosificacion rectal medicamentosa.

Info

Publication number
ES2001061A6
ES2001061A6 ES8600834A ES8600834A ES2001061A6 ES 2001061 A6 ES2001061 A6 ES 2001061A6 ES 8600834 A ES8600834 A ES 8600834A ES 8600834 A ES8600834 A ES 8600834A ES 2001061 A6 ES2001061 A6 ES 2001061A6
Authority
ES
Spain
Prior art keywords
ceftriaxone
dosage forms
rectal dosage
rectal
glycerides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600834A
Other languages
English (en)
Inventor
Charanjit Behl
Joel Unowsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES2001061A6 publication Critical patent/ES2001061A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN PROCEDIMIENTO PARA LA PREPARACION DE UNA FORMA DE DOSIFICACION RECTAL MEDICAMENTOSA, PARTICULARMENTE SUPOSITORIOS, QUE CONTIENEN UNA DOSIS MEDICAMENTOSA DE UN ANTIBIOTICO DE BETA-LACTAMA COMO INGREDIENTE ACTIVO, EN UN VEHICULO ADECUADO, INCORPORANDO EN LA FORMULACION ACIDO QUENODEOXICOLICO O SU SAL SODICA COMO MEJORADOR PROMOVEDOR DE LA ABSORCION DEL ANTIBIOTICO, LOGRANDO UN NIVEL ADECUADO EN SANGRE.
ES8600834A 1985-08-05 1986-08-04 Un procedimiento para la preparacion de una forma de dosificacion rectal medicamentosa. Expired ES2001061A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/762,248 US4760059A (en) 1985-08-05 1985-08-05 Rectal dosage form

Publications (1)

Publication Number Publication Date
ES2001061A6 true ES2001061A6 (es) 1988-04-16

Family

ID=25064508

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8600834A Expired ES2001061A6 (es) 1985-08-05 1986-08-04 Un procedimiento para la preparacion de una forma de dosificacion rectal medicamentosa.

Country Status (17)

Country Link
US (1) US4760059A (es)
EP (1) EP0211434A3 (es)
JP (1) JPS6233129A (es)
KR (1) KR870001826A (es)
CN (1) CN86105639A (es)
AU (1) AU6082886A (es)
DK (1) DK371786A (es)
ES (1) ES2001061A6 (es)
FI (1) FI863170A (es)
GR (1) GR862050B (es)
HU (1) HU195732B (es)
IL (1) IL79607A0 (es)
MC (1) MC1765A1 (es)
NO (1) NO863138L (es)
PT (1) PT83135A (es)
ZA (1) ZA865182B (es)
ZW (1) ZW15686A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA876930B (en) * 1986-10-07 1988-05-25 Hoffmann La Roche Pharmaceutical compositions
US5190748A (en) * 1988-11-22 1993-03-02 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
CN104906336A (zh) * 2015-06-09 2015-09-16 杨秦 止咳桃花散用于制备直肠给药制剂的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1563311A (en) * 1975-09-26 1980-03-26 Yamanouchi Pharma Co Ltd Pharmaceutical composition of insulin for rectal use
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS5517342A (en) * 1978-07-25 1980-02-06 Toyama Chem Co Ltd Cephalosporin composition for rectal administaration
JPS5562007A (en) * 1978-11-02 1980-05-10 Fujisawa Pharmaceut Co Ltd Preparation for rectal administration
US4406896A (en) * 1979-12-20 1983-09-27 Merck & Co., Inc. Adjuvants for rectal delivery of drug substances
JPS5764610A (en) * 1980-10-08 1982-04-19 Fujisawa Pharmaceut Co Ltd Pharmaceutical for rectal administration
JPS57158719A (en) * 1981-03-24 1982-09-30 Fujisawa Pharmaceut Co Ltd Rectal administration pharmaceutical
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration

Also Published As

Publication number Publication date
ZA865182B (en) 1987-03-25
ZW15686A1 (en) 1988-03-30
EP0211434A3 (de) 1987-10-07
GR862050B (en) 1986-12-24
NO863138L (no) 1987-02-06
MC1765A1 (fr) 1987-07-17
AU6082886A (en) 1987-02-12
FI863170A0 (fi) 1986-08-04
HUT41635A (en) 1987-05-28
US4760059A (en) 1988-07-26
NO863138D0 (no) 1986-08-04
EP0211434A2 (de) 1987-02-25
CN86105639A (zh) 1987-02-25
KR870001826A (ko) 1987-03-28
DK371786D0 (da) 1986-08-04
IL79607A0 (en) 1986-11-30
FI863170A (fi) 1987-02-06
HU195732B (en) 1988-07-28
PT83135A (pt) 1986-09-01
JPS6233129A (ja) 1987-02-13
DK371786A (da) 1987-02-06

Similar Documents

Publication Publication Date Title
JPS5664792A (en) Continuous enzymatic conversion of water soluble alphaaketocarboxylic acid to corresponding to amino acid
DE3366019D1 (en) Phosphinylalkanoyl substituted imino acids
JPS5664791A (en) Continuous enzymatic conversion of water soluble alphaaketocarboxylic acid to corresponding alphaahydroxycarboxylic acid
DE3662192D1 (en) Proces for the preparation of mobile pastes of tensio-active salts of esters of fatty acid sulphonic acids with a high solids content
NZ183323A (en) Administration of enzyme composition to livestock to promote milk production
JPS6485277A (en) Heat storage material
JPS5390238A (en) Preparation of arom. cyano cpds.
GB8520462D0 (en) Normally liquid c14 to c18 monoalkyl catechols
ES525463A1 (es) Procedimiento para la preparacion de acidos alfa-arilalcanoicos
GB2099008B (en) Enzymatic process for the treatment of xanthan gums to improve the filtrability of their aqueous solutions
ES424294A1 (es) Procedimiento para la preparacion de una solucion acuosa de jabon liquido.
ES2001061A6 (es) Un procedimiento para la preparacion de una forma de dosificacion rectal medicamentosa.
GB2017735B (en) Stabilised acid-containing anaerobic compositions
JPS5484092A (en) Production of long chain aliphatic acids by microorganism
ZW5389A1 (en) The use of calcium sulphate to improve the fermentation of organic waste
JPS5632435A (en) Manufacture of organic saturated fatty acid monocarboxylic acid
JPS53147691A (en) Method of producing transparent solution of magnesium salt for anion surface acitive agnet
GB2004564A (en) Superfitting Roof Bars
ES8401074A1 (es) Sal de n-metil-d-glucamina.
JPS5424826A (en) Preparation of salt of alcohol sulfuric acid ester
JPS53135930A (en) Preparation of magnesium salt of sulfonic acid ester or sulfuric acid ester
JPS53112859A (en) Production of 1-methyladamantane
KR900700417A (ko) 유기폐기물의 발효의 개량을 위한 황산칼슘의 사용
JPS5396095A (en) Preparation of polyester
ES450125A1 (es) Procedimiento para la preparacion de acidos -(6,11-dihidro- 11-oxodibenz (b,e) oxepin-2-il)-alcanoicos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19890805